Brandes Investment Partners’s Syneron Medical Ltd ELOS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-2,901,971
| Closed | -$31.9M | – | 174 |
|
|
2017
Q3 | $31.9M | Sell |
2,901,971
-553,126
| -16% | -$6.06M | 0.65% | 51 |
|
|
2017
Q2 | $37.8M | Sell |
3,455,097
-225,667
| -6% | -$2.47M | 0.6% | 50 |
|
|
2017
Q1 | $38.8M | Buy |
3,680,764
+20,151
| +0.6% | +$195K | 0.58% | 50 |
|
|
2016
Q4 | $30.7M | Buy |
3,660,613
+245,700
| +7% | +$1.93M | 0.46% | 55 |
|
|
2016
Q3 | $24.4M | Buy |
3,414,913
+691,378
| +25% | +$4.81M | 0.37% | 59 |
|
|
2016
Q2 | $20.9M | Buy |
2,723,535
+214,089
| +9% | +$1.53M | 0.32% | 61 |
|
|
2016
Q1 | $18.3M | Buy |
2,509,446
+763,777
| +44% | +$5.47M | 0.26% | 68 |
|
|
2015
Q4 | $13.5M | Buy |
1,745,669
+1,175,299
| +206% | +$8.96M | 0.2% | 77 |
|
|
2015
Q3 | $4.08M | Sell |
570,370
-60
| -0% | -$576 | 0.06% | 96 |
|
|
2015
Q2 | $6.06M | Sell |
570,430
-295,890
| -34% | -$3.46M | 0.08% | 93 |
|
|
2015
Q1 | $10.7M | Sell |
866,320
-1,472,210
| -63% | -$16.3M | 0.15% | 81 |
|
|
2014
Q4 | $21.8M | Buy |
2,338,530
+38,510
| +2% | +$371K | 0.31% | 60 |
|
|
2014
Q3 | $23M | Buy |
2,300,020
+222,390
| +11% | +$2.26M | 0.31% | 57 |
|
|
2014
Q2 | $21.4M | Buy |
2,077,630
+502,760
| +32% | +$5.43M | 0.26% | 58 |
|
|
2014
Q1 | $19.6M | Sell |
1,574,870
-589,267
| -27% | -$6.98M | 0.25% | 59 |
|
|
2013
Q4 | $26.6M | Buy |
2,164,137
+399,119
| +23% | +$4.15M | 0.33% | 57 |
|
|
2013
Q3 | $15.2M | Buy |
1,765,018
+226,669
| +15% | +$1.96M | 0.2% | 64 |
|
|
2013
Q2 | $13.4M | Buy |
+1,538,349
| New | +$13.8M | 0.17% | 69 |
|
Brandes Investment Partners's ELOS Position: Q4 2017 in Review
Brandes Investment Partners sold out of Syneron Medical Ltd (ELOS) in Q4 2017, closing a stake of 2,901,971 shares — an estimated $31.9M sold.
Brandes Investment Partners first reported a position in ELOS in Q2 2013 and held it in 18 quarters. The position peaked at $38.8M in Q1 2017. 1 fund tracked by Wall St. Rank holds ELOS as of Q4 2017.
- Brandes Investment Partners reported no remaining Syneron Medical Ltd position as of Q4 2017 after selling out during the quarter.
- Brandes Investment Partners sold 2,901,971 Syneron Medical Ltd shares in Q4 2017, an estimated $31.9M.
- Brandes Investment Partners first reported a position in Syneron Medical Ltd in Q2 2013 and held it in 18 quarters.
- Brandes Investment Partners's Syneron Medical Ltd position peaked at $38.8M in Q1 2017.
- 1 fund tracked by Wall St. Rank held Syneron Medical Ltd as of Q4 2017.
Based on Brandes Investment Partners's 13F filing for Q4 2017, filed 12 Feb 2018.